As a traditional public health intervention, vaccines have been costing more money in recent years when a couple of newer generation of products are exhausting governments’ budgets.
The university appears to be representing pharmaceutical companies Pfizer, Medivation and Astellas in its patent battle. They aren’t telling the Delhi high court this, but they do talk about it in other documents.
Not only was Pfizer given a subsidy to ‘develop’ a drug that already existed, the profits they will make from the inefficient vaccine is much beyond what was originally stipulated.
Pneumonia kills two lakh children in India every year, but the vaccine has so far been available only in the private market at a high price.
The study said continued surveillance to determine the true frequency of the gene in the US is critical.